Mindways Software Appoints Eukon as Distributor in Italy

July 9, 2014 - PRLog -- Austin, TX Mindways Software, a leading medical device software applications provider, has signed a distributorship agreement with EUKON srl, to deploy QCT Pro™ bone densitometry systems throughout Italy.

Mindways’ QCT Pro™ (http://qct.com/products/) low-dose CT bone densitometry systems enable health care providers worldwide to benefit from the latest BMD screening technology without costly dedicated specialist equipment or operators. QCT Pro™ software produces bone densitometry reports for both spine and hip from a low-dose abdominal CT scan with radiation doses comparable to a mammogram.

Mindways VP of Business Development, Alan Brett said: “Health facilities are increasingly searching for affordable, effective bone-density testing alternatives to screen a growing number of patients at risk from osteoporosis. We are very pleased to partner with EUKON to provide a quality, advanced imaging technology to the local market for the accurate diagnosis and treatment of osteoporosis and low bone mineral density.”

EUKON Managing Director, Gennaro Broya de Lucia said, “The International Osteoporosis Foundation reports that osteoporotic fractures cost Italy over €7 billion but it is both underdiagnosed and undertreated among postmenopausal women. Offering an advanced imaging application such as Mindways QCT Pro™ forms an integral part of combatting the disease and fits in with our ongoing efforts to bring world class radiology technology to Italy.”

Adopting Mindways’ QCT software has the benefit of low capital investment while reducing on-going investment in site, personnel and maintenance costs by allowing hospitals and medical practices to make use of their existing CT infrastructure and address the growing problem of osteoporosis.

QCT bone densitometry services produce DXA-equivalent hip reports for less than the cost of buying and operating a DXA machine. Additionally, spine measurements are made in the trabecular bone volume only where the exceptional sensitivity to BMD change allows for the earliest possible diagnosis of osteoporotic conditions. Because QCT scans take less than five minutes of CT scanner time, healthcare organizations can address the growing volumes of patient traffic through improved equipment utilization without overburdening them. BMD measurements made using QCT are also used extensively in pharmaceutical clinical trials.

For more information on Mindways Software and QCT Pro™, please visit www.qct.com.

About  EUKON srl

EUKON has led the market in advanced analysis and visualization in Italy since 2007 with more than 60 active installations. The company distributes high end specialist solutions from vendor independent partners such as: Intrasense, Circle Cardiovascular Imaging, Imagilys, Apollo, Cadens and recently Mindways, covering the most important diagnostic necessities of radiology departments with dedicated and highly effective tools that complement those of the major equipment suppliers. EUKON demonstrates a strong commitment to excellent customer experience and satisfaction by providing solutions to their exact requirements and giving genuine support to their clinical and research oriented activities.

Please visit www.eukon.it for further information.

About Mindways Software, Inc.

Mindways produces low-dose CT bone densitometry products for spine and hip bone density measurements. Mindways premier product, QCT Pro™ uses Quantitative CT (QCT) images to derive DXA-like hip BMD measurements and volumetric spine BMD measurements. QCT Pro™ hip BMD measurements are interpreted in the same manner as DXA, while spine measurements provide exceptional sensitivity to short-term bone density change. QCT Pro™ is fast, easy to use, reimbursable, and provides the same clinical utility as DXA at a fraction of its cost.

For more information visit: www.qct.com.

Media Contact:

Alan Brett, VP Business Development

+1 512 912 0871

alan@qct.com